Replies to post #150 on TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

Good to hear, I would have loved to attended- just couldn't get away.

Was there much discussion on the TSC101 CD4*CD8* part of the trial.

From the poster presentation this looks most interesting ( far right slides - TSC101 CD4*CD*/ UD Chimerism/ TP53

https://www.tscan.com/wp-content/uploads/2023/05/ASGCT-poster-2023.pdf